You may also like
A Novel Antidote-Controlled Anticoagulant Reduces Thrombin Generation and Inflammation and Improves Cardiac Function in Cardiopulmonary Bypass Surgery
Here we demonstrate that an anticoagulant aptamer-antidote pair targeting factor IXa can replace heparin and protamine in a porcine CPB model and also limit the adverse effects on thrombin generation, inflammation, and cardiac physiology associated with heparin and protamine use.
Regeneration of Mammalian Cardiomyocytes Demonstrate
Unlike normal mammalian cardiac tissue, the hearts of the MRL mouse strain can regenerate cardiomyocytes following infarction, with full recovery of myocardial […]
The Incidence, Risk Factors, and Prognosis of Postoperative Hyperbilirubinemia after Cardiac Surgery: A Systematic Review and Meta-Analysis
Hyperbilirubinemia was common and was associated with increased in-hospital mortality. Preoperative high right atrial pressure, high TB concentration, prolonged CPB and ACC time, and a large amount of blood transfused were the commonly observed risk factors for postoperative hyperbilirubinemia in cardiac surgery patients. Addressing these risk factors may be helpful to lower the occurrence of postoperative hyperbilirubinemia.